Catalyst Wire Dossier Catalyst Wire Dossier

AM1030-CREAM

· AnaMar AB
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AM1030-CREAM, covering 2015-12-11 to 2015-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis [Phase 1, Phase 2]

See pricing